NorthStar Asset Management (Pennsylvania)’s Gilead Sciences GILD Stock Holding History

NorthStar Asset Management (Pennsylvania)’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-9,235	Closed	-$934K	–	113
2015 Q4	$934K	Buy	9,235 +180	+2%	+$18.7K	0.4%	56
2015 Q3	$890K	Hold	9,055	–	–	0.4%	56
2015 Q2	$1.06M	Buy	9,055 +400	+5%	+$43.7K	0.44%	53
2015 Q1	$850K	Sell	8,655 -400	-4%	-$40.6K	0.36%	59
2014 Q4	$854K	Sell	9,055 -1,150	-11%	-$119K	0.37%	59
2014 Q3	$1.09M	Buy	10,205 +150	+1%	+$14.7K	0.47%	50
2014 Q2	$834K	Buy	+10,055	New	+$783K	0.35%	60

Other funds holding GILD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

NorthStar Asset Management (Pennsylvania)'s GILD Position: Q1 2016 in Review

NorthStar Asset Management (Pennsylvania) sold out of Gilead Sciences (GILD) in Q1 2016, closing a stake of 9,235 shares — an estimated $934K sold.

NorthStar Asset Management (Pennsylvania) first reported a position in GILD in Q2 2014 and held it in 7 quarters. The position peaked at $1.09M in Q3 2014. 1,630 funds tracked by Wall St. Rank hold GILD as of Q1 2016.

NorthStar Asset Management (Pennsylvania) reported no remaining Gilead Sciences position as of Q1 2016 after selling out during the quarter.
NorthStar Asset Management (Pennsylvania) sold 9,235 Gilead Sciences shares in Q1 2016, an estimated $934K.
NorthStar Asset Management (Pennsylvania) first reported a position in Gilead Sciences in Q2 2014 and held it in 7 quarters.
NorthStar Asset Management (Pennsylvania)'s Gilead Sciences position peaked at $1.09M in Q3 2014.
1,630 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2016.

Based on NorthStar Asset Management (Pennsylvania)'s 13F filing for Q1 2016, filed 2 May 2016.